Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint Venture

(NASDAQ:LMRI) Lumexa Imaging announced a new joint venture with Advocate Health to expand its outpatient imaging services in Illinois. This agreement marks Lumexa Imaging’s entry into Illinois and builds on its existing partnership with Advocate Health. With this new joint venture, Lumexa Imaging now has 10 joint ventures with 9 health systems. The company describes this as part of its ongoing strategy to expand its presence in attractive healthcare markets and to bring high-quality, convenient care closer to patients and referring providers. Caitlin Zulla, Chief Executive Officer of Lumexa Imaging, stated that expanding the relationship with Advocate Health into Illinois is an important milestone for the company. She emphasized that Lumexa Imaging’s success in partnering with health systems is a key differentiator as health systems seek to expand outpatient imaging capabilities and participate in the shift toward lower-cost settings. The new Illinois joint venture is described as advancing Lumexa Imaging’s disciplined geographic expansion strategy, which includes health system partnerships, de novo development, and acquisitions. The company remains focused on deploying capital efficiently in markets where it sees opportunities for sustainable, long-term growth. Lumexa Imaging is a nationwide provider of outpatient medical imaging. The company has over 5,000 team members and approximately 190 outpatient imaging centers. In 2025, Lumexa Imaging conducted approximately 4 million outpatient procedures system-wide. The company positions itself as a partner of choice for health systems and radiologists, delivering clinical excellence, operations, and state-of-the-art technology across its platform.

Lumexa Imaging Announces First Quarter 2026 Results

Lumexa Imaging (NASDAQ:LMRI) reported its first quarter 2026 results, showing consolidated revenues of $252.5 million, a 3.1% increase from $245.0 million in Q1 2025. Net income was $1.7 million compared to a net loss of $7.7 million in the prior year period. The company reiterated its full year 2026 guidance, expecting consolidated revenues of $1.045 to $1.097 billion and adjusted EBITDA of $234 to $242 million. Key operational highlights include same-center advanced volume growth of 5.6% and the addition of four new imaging centers. These results and outlook reflect continued growth and expansion in Lumexa Imaging's outpatient imaging services business.